Ancilia develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. Our approach harnesses the natural function of CRISPR to enhance bacterial immunity against viruses and effectively modulate the human microbiome.Something looks off?
Open jobs at Ancilia Biosciences
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.